Christos Papagiannopoulos

1PUBLICATIONS
8CO-AUTHORS
Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Feb 21, 2022
Efficacy and safety of first-line therapies in <i>EGFR</i>-mutated advanced non-small-cell lung cancer: a network meta-analysis.

Katrin Haeussler, Xuan Wang, Katherine B Winfree

Pageof 1

Frequent Collaborators

1 joint publications

Katrin Haeussler

1 joint publications

Xuan Wang

1 joint publications

Katherine B Winfree

1 joint publications

Yulia D'yachkova

1 joint publications

Sory Traore

1 joint publications

Tarun Puri

1 joint publications

Howard Thom

1 joint publications

Maria Nassim

Frequent Collaborators

1 joint publications

Katrin Haeussler

1 joint publications

Xuan Wang

1 joint publications

Katherine B Winfree

1 joint publications

Yulia D'yachkova

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure
09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

8.9K
See more related videos

Top Related Videos

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure
09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

8.9K
See more related videos